DLBCL GERMINAL CENTER B-CELL TYPE
Clinical trials for DLBCL GERMINAL CENTER B-CELL TYPE explained in plain language.
Never miss a new study
Get alerted when new DLBCL GERMINAL CENTER B-CELL TYPE trials appear
Sign up with your email to follow new studies for DLBCL GERMINAL CENTER B-CELL TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety of a new oral drug called SGR-1505 in adults with various types of relapsed or hard-to-treat B-cell cancers, like non-Hodgkin lymphoma and chronic lymphocytic leukemia. The main goal is to find the highest dose patients can tolera…
Matched conditions: DLBCL GERMINAL CENTER B-CELL TYPE
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists test new Two-Pronged attack on tough blood cancers
Disease control Recruiting nowThis is a small, early-stage study for adults with B-cell leukemia or lymphoma that has come back or not responded to other treatments. The goal is to test the safety of a new two-step approach. First, patients receive a targeted radioactive drug (131-I apamistamab), followed by …
Matched conditions: DLBCL GERMINAL CENTER B-CELL TYPE
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC